Monday, February 13, 2023
The first portable magnetic resonance imaging (MRI) system for studying the brain was approved by the U.S. FDA, according to a statement from Hyperfine.
With increases in signal-to-noise ratio, the most current version of Swoop® software enhances the image quality of the diffusion-weighting imaging (DWI) sequence.
The Swoop® Portable MR Imaging® System field of view for T1, T2, and FLAIR sequences is also increased by 10% in this software version to match the previously enhanced DWI sequence's 20cm field of view. For deep brain pathology to be visualized, the field of vision must be large.
Hyperfine, Inc. first received FDA approval in 2020 for the Swoop® Portable MR Imaging® System. Since then, the company has received two more FDA clearances for hardware upgrades and seven clearances for upgraded software, including BrainInsight™ software—five of these clearances in 2022. Twenty peer-reviewed clinical publications have used Swoop® system data, and Hyperfine, Inc. keeps a total installed base* of 100 Swoop® systems globally.